What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally
AnaptysBioAnaptysBio(US:ANAB) The Motley Fool·2026-01-11 23:18

This biotech innovator in antibody therapies just reported a significant insider sale amid a period of strong share price gains.On Dec. 23, AnaptysBio (ANAB +1.99%) Director J. Anthony Ware executed an open-market sale of 3,900 shares for a transaction value of 193,342.50,representing28.82193,342.50, representing 28.82% of his direct holdings, according to an SEC Form 4 filing.Transaction summaryMetricValueShares sold (direct)3,900Transaction value193,342.50Post-transaction shares (direct)9,630Post-transaction value (direct ownershi ...